Developing Novel IBD Therapeutics Using Artificial Intelligence & Machine Learning

Time: 2:30 pm
day: Day Two


  • Utilizing artificial intelligence and computational modelling to identify enzyme based novel drug targets
  • Harnessing artificial intelligence to identify novel biomarkers of IBD to better inform trial design and patient subgroup
  • Leveraging machine learning to improve IBD data analysis